Timothy Mcinerney

Insider Reports History

Signature
/s/ Rhonda Hellums, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Timothy Mcinerney:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Silence Therapeutics plc Director Share Option (Right to Buy) 48K May 5, 2025 Direct

Insider Reports Filed by Timothy Mcinerney

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SLN Silence Therapeutics plc May 5, 2025 1 $0 4 May 20, 2025 Director
SLN Silence Therapeutics plc May 5, 2025 0 $0 3 May 20, 2025 Director